United States · General news · NBC News

Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial

Published by NBC News · United States 2 h ago

Moderna and Merck’s personalized mRNA vaccine for melanoma reduced the risk of cancer recurrence and death by 42% compared with standard treatment in a trial.

Read the full article on NBC News Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nbcnews.com)

Also worth reading

Mongabay

Bangladesh’s climate migrants are arriving in cities unprepared to protect them

The Hill

DeSantis gifts Trump gold coin with engraved image of him ‘flipping the bird’

Fox News

CHAOS INC.: Who's who in the global mayhem network? Communists, Antifa, agitators in the red-green alliance.

ABC News

Vance could be a major Category 3 hurricane Friday as it nears Mexico

New York Post

Registered sex offender, 29, busted trying to enroll in high school as teen girl — and it’s not his first time

PBS NewsHour